Skip to content

Effect of Sufentanil and Ropivacaine

Effect of 0.5µg/ml Sufentanil and Ropivacaine Towards Pregnant Women and Fetus in Analgesia Labor

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02488291
Enrollment
120
Registered
2015-07-02
Start date
2014-04-30
Completion date
2015-06-30
Last updated
2020-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia Complications

Keywords

Epidural, Analgesia labor, Perinatal, anesthesia

Brief summary

The investigators study the efficacy of epidural sufentanil/ropivacaine for analgesia labor in primiparas so as to decrease perinatal complications of analgesia labor.

Detailed description

A prospective study of 120 full-term parturients receiving labor analgesia were randomly assigned into 2 groups: the 0.5Sufen group (N=60), the 0.25Sufen group (N=60).

Interventions

DRUG0.25 sufentanil

with different dosage

DRUG0.5µg/ml sufentanil

0.5µg/ml sufentanil

0.1% ropivacaine

Sponsors

Shanghai Jiao Tong University School of Medicine
CollaboratorOTHER
Fudan University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 35 Years
Healthy volunteers
No

Inclusion criteria

1. Patients had regular prenatal examinations at the outpatient clinic; 2. They were between 25 to 35 years of age) 3. They had a gestational age ≥37 weeks and \< 42 weeks; 4. They had an estimated fetal weight ≥ 2,500 g and \< 4,200 g.

Exclusion criteria

* a history of spinal surgery, * platelet count \<100×109 /L , * coagulation disorder, * sensorimotor disorder of lower extremity, * leg pain, * puncture point infection, * heart disease history, * pulmonary disease, * liver and renal function disorder and * a history of neuropsychiatry drugs.

Design outcomes

Primary

MeasureTime frameDescription
VAS(visual analog pain score)1 yearcomparison with two groups

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026